Bill > SB926

This bill requires Oklahoma's Medicaid program to cover insulin and insulin delivery systems when medically necessary for diabetes management, with specific provisions for including tubeless, wearable insulin pumps that can automatically deliver insulin. The Oklahoma Health Care Authority is directed to seek any required federal approval to implement these coverage requirements. The bill is set to become effective on July 1, 2025, and includes an emergency clause suggesting the urgency of the legislation for public health purposes. By mandating coverage of these critical diabetes management tools, the bill aims to improve access to essential medical technologies for Medicaid recipients with diabetes, potentially reducing financial barriers to necessary diabetes care. The inclusion of the emergency clause and the specific language about seeking federal approval indicate a comprehensive approach to ensuring that Medicaid patients can receive advanced insulin delivery technologies without undue financial strain.

Health and Social Services

http://www.oklegislature.gov/BillInfo.aspx?Bill=sb926&Session=2600